Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinryze for Acute HAE Attacks
NCT00438815Phase 3Completed
- Sponsor
- Takeda
- Start
- Sep 2006
- Primary completion
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of c1-esterase inhibitor in hereditary angioedema (HAE), sponsored by Takeda. Started Sep 2006; status: completed.
02
Drugs
c1-esterase inhibitor
03
Conditions
hereditary angioedema (HAE)
Beyond the preview
Go deeper on NCT00438815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00438815.